Orphan market

DelveInsight’s Orphan disease market reports cover orphan indications, their epidemiology and treatment and therapies in the pipeline and available in the market.

Cost ineffective Orphan Drugs limit the access

Business Consultant, DelveInsight's Drug Report, Orphan market, Pharma Consultant

Rare diseases are mostly serious, chronic and life-threatening, associated with both psychological as well as financial burdens. In...

Read More


Business Consultant, Notizia, Orphan market, Pharma Consultant, Rising of Orphan Drug Development

Food and Drug Administration repudiates ADHD drug by Sunovion Sunovion’s ADHD drug for the treatment of attention-deficit hyperactivity...

Read More

Fatty Acid Amide Hydrolase (FAAH) Inhibitors – Pipeline Insights, 2015 – A DelveInsight’s Report

CNS Indications, CVS Indications, new therapeutic target, Oncology based Indications, Orphan market

Fatty acid amide hydrolase (FAAH) is an intracellular amidase signature family of serine hydrolases enzyme, which catalyzes the hydrolysis...

Read More